# FDA recall D-0290-2025

> **Mylan Institutional, Inc.** · Class II · drug recall initiated 2025-03-07.

## Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

## Reason for recall

Super-Potent Drug: Out of specification potency results were obtained.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0290-2025
- **Recalling firm:** Mylan Institutional, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-03-07
- **Report date:** 2025-03-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rockford, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0290-2025

## Citation

> AI Analytics. FDA recall D-0290-2025. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-0290-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*